• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC121400
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 02/06/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), users are made aware of the risks associated with type ii endoleaks and are instructed to consider the risks and benefits discussed in the ifu for each patient before using the devices.Additionally, per ifu, adverse events that may occur and / or require intervention include, but are not limited to endoleak and aneurysm enlargement. .
 
Event or Problem Description
It was reported that on (b)(6) 2019, the patient presented with an abdominal aortic aneurysm and was treated with gore® excluder® aaa endoprostheses.On (b)(6) 2020, a type ib endoleak on the gore® excluder® aaa contralateral leg endoprosthesis was identified that appears to have limited seal.Additionally a type ii endoleak originating from the inferior mesenteric artery (ima) was identified.On (b)(6) 2020, the type ib endoleak was treated with the implantation of an additional endoprosthesis (gore® viabahn® vbx balloon expandable endoprosthesis)that serves as an extension on the contralateral side.The type ii endoleak was solved by coiling of the ima on the same day.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9828786
Report Number3013164176-2020-00037
Device Sequence Number11495241
Product Code MIH
UDI-Device Identifier00733132618644
UDI-Public00733132618644
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Operator of Device Health Professional
Device Expiration Date08/13/2022
Device Model NumberPLC121400
Device Catalogue NumberPLC121400
Device Lot Number20965203
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/13/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-